Condition

Breast Cancer (1)

Colon Cancer (1)

Medullary Thyroid Cancer (1)

Non Small Cell Lung Cancer (1)

Other Solid Tumors With Evidence of Activating RET Alteration (1)

Pancreatic Cancer (1)

Papillary Thyroid Cancer (1)

Overall Status

Available (1)

Sign in for free

Phase

Sponsor

Loxo Oncology, Inc. (1)

Collaborator

Eli Lilly and Company (1)

Intervention

selpercatinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Expanded Access (1)

other solid tumors with evidence of activating ret alteration

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available

Non Small Cell Lung Cancer
+6 more

Selpercatinib

Goodyear, Arizona
+67 more

Aug 17, 2022